Next Quarterly Earnings
Wednesday, June 2, 2027
Expected
Avalyn Pharma is a US-based biopharmaceutical company specializing in innovative therapies for pulmonary diseases. Through cutting-edge inhalation technology, the company effectively improves the treatment of patients suffering from chronic respiratory conditions.
Avalyn Pharma last reported quarterly earnings on 8/12/2026 (Q2 2026). Earnings per share (EPS) came in at -0.98 USD.
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.